Literature DB >> 30076276

White matter lesions: Spatial heterogeneity, links to risk factors, cognition, genetics, and atrophy.

Mohamad Habes1, Aristeidis Sotiras2, Guray Erus2, Jon B Toledo2, Deborah Janowitz2, David A Wolk2, Haochang Shou2, Nick R Bryan2, Jimit Doshi2, Henry Völzke2, Ulf Schminke2, Wolfgang Hoffmann2, Susan M Resnick2, Hans J Grabe2, Christos Davatzikos2.   

Abstract

OBJECTIVES: To investigate spatial heterogeneity of white matter lesions or hyperintensities (WMH).
METHODS: MRI scans of 1,836 participants (median age 52.2 ± 13.16 years) encompassing a wide age range (22-84 years) from the cross-sectional Study of Health in Pomerania (Germany) were included as discovery set identifying spatially distinct components of WMH using a structural covariance approach. Scans of 307 participants (median age 73.8 ± 10.2 years, with 747 observations) from the Baltimore Longitudinal Study of Aging (United States) were included to examine differences in longitudinal progression of these components. The associations of these components with vascular risk factors, cortical atrophy, Alzheimer disease (AD) genetics, and cognition were then investigated using linear regression.
RESULTS: WMH were found to occur nonuniformly, with higher frequency within spatially heterogeneous patterns encoded by 4 components, which were consistent with common categorizations of deep and periventricular WMH, while further dividing the latter into posterior, frontal, and dorsal components. Temporal trends of the components differed both cross-sectionally and longitudinally. Frontal periventricular WMH were most distinctive as they appeared in the fifth decade of life, whereas the other components appeared later in life during the sixth decade. Furthermore, frontal WMH were associated with systolic blood pressure and with pronounced atrophy including AD-related regions. AD polygenic risk score was associated with the dorsal periventricular component in the elderly. Cognitive decline was associated with the dorsal component.
CONCLUSIONS: These results support the hypothesis that the appearance of WMH follows age and disease-dependent regional distribution patterns, potentially influenced by differential underlying pathophysiologic mechanisms, and possibly with a differential link to vascular and neurodegenerative changes.
© 2018 American Academy of Neurology.

Entities:  

Mesh:

Year:  2018        PMID: 30076276      PMCID: PMC6139818          DOI: 10.1212/WNL.0000000000006116

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

1.  White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury.

Authors:  Malee S Fernando; Julie E Simpson; Fiona Matthews; Carol Brayne; Claire E Lewis; Robert Barber; Raj N Kalaria; Gill Forster; Filomena Esteves; Stephen B Wharton; Pamela J Shaw; John T O'Brien; Paul G Ince
Journal:  Stroke       Date:  2006-04-20       Impact factor: 7.914

2.  Associations of carotid artery intima-media thickness (IMT) with risk factors and prevalent cardiovascular disease: comparison of mean common carotid artery IMT with maximum internal carotid artery IMT.

Authors:  Joseph F Polak; Michael J Pencina; Allison Meisner; Karol M Pencina; Lisa S Brown; Philip A Wolf; Ralph B D'Agostino
Journal:  J Ultrasound Med       Date:  2010-12       Impact factor: 2.153

3.  Cohort profile: the study of health in Pomerania.

Authors:  Henry Völzke; Dietrich Alte; Carsten Oliver Schmidt; Dörte Radke; Roberto Lorbeer; Nele Friedrich; Nicole Aumann; Katharina Lau; Michael Piontek; Gabriele Born; Christoph Havemann; Till Ittermann; Sabine Schipf; Robin Haring; Sebastian E Baumeister; Henri Wallaschofski; Matthias Nauck; Stephanie Frick; Andreas Arnold; Michael Jünger; Julia Mayerle; Matthias Kraft; Markus M Lerch; Marcus Dörr; Thorsten Reffelmann; Klaus Empen; Stephan B Felix; Anne Obst; Beate Koch; Sven Gläser; Ralf Ewert; Ingo Fietze; Thomas Penzel; Martina Dören; Wolfgang Rathmann; Johannes Haerting; Mario Hannemann; Jürgen Röpcke; Ulf Schminke; Clemens Jürgens; Frank Tost; Rainer Rettig; Jan A Kors; Saskia Ungerer; Katrin Hegenscheid; Jens-Peter Kühn; Julia Kühn; Norbert Hosten; Ralf Puls; Jörg Henke; Oliver Gloger; Alexander Teumer; Georg Homuth; Uwe Völker; Christian Schwahn; Birte Holtfreter; Ines Polzer; Thomas Kohlmann; Hans J Grabe; Dieter Rosskopf; Heyo K Kroemer; Thomas Kocher; Reiner Biffar; Ulrich John; Wolfgang Hoffmann
Journal:  Int J Epidemiol       Date:  2010-02-18       Impact factor: 7.196

4.  Region of interest correction factors improve reliability of diffusion imaging measures within and across scanners and field strengths.

Authors:  Vijay K Venkatraman; Christopher E Gonzalez; Bennett Landman; Joshua Goh; David A Reiter; Yang An; Susan M Resnick
Journal:  Neuroimage       Date:  2015-07-02       Impact factor: 6.556

Review 5.  Diversity of native nicotinic receptor subtypes in mammalian brain.

Authors:  Michele Zoli; Francesco Pistillo; Cecilia Gotti
Journal:  Neuropharmacology       Date:  2014-11-25       Impact factor: 5.250

6.  Periventricular hyperintensities are associated with elevated cerebral amyloid.

Authors:  Michael Marnane; Osama O Al-Jawadi; Shervin Mortazavi; Kathleen J Pogorzelec; Bing Wei Wang; Howard H Feldman; Ging-Yuek R Hsiung
Journal:  Neurology       Date:  2016-01-08       Impact factor: 9.910

7.  The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study.

Authors:  Ewoud J van Dijk; Monique M B Breteler; Reinhold Schmidt; Klaus Berger; Lars-Göran Nilsson; Matthijs Oudkerk; Andrzej Pajak; Susana Sans; Maria de Ridder; Carole Dufouil; Rebecca Fuhrer; Simona Giampaoli; Lenore J Launer; Albert Hofman
Journal:  Hypertension       Date:  2004-10-04       Impact factor: 10.190

8.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

9.  Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's disease.

Authors:  Charles D Smith; Eleanor S Johnson; Linda J Van Eldik; Gregory A Jicha; Frederick A Schmitt; Peter T Nelson; Richard J Kryscio; Ronan R Murphy; Clinton V Wellnitz
Journal:  Brain Behav       Date:  2016-02-16       Impact factor: 2.708

10.  Advanced brain aging: relationship with epidemiologic and genetic risk factors, and overlap with Alzheimer disease atrophy patterns.

Authors:  M Habes; D Janowitz; G Erus; J B Toledo; S M Resnick; J Doshi; S Van der Auwera; K Wittfeld; K Hegenscheid; N Hosten; R Biffar; G Homuth; H Völzke; H J Grabe; W Hoffmann; C Davatzikos
Journal:  Transl Psychiatry       Date:  2016-04-05       Impact factor: 6.222

View more
  35 in total

Review 1.  Neurovascular and Cognitive Dysfunction in Hypertension.

Authors:  Costantino Iadecola; Rebecca F Gottesman
Journal:  Circ Res       Date:  2019-03-29       Impact factor: 17.367

2.  Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.

Authors:  Konstantinos Arfanakis; Arnold M Evia; Sue E Leurgans; Luis F C Cardoso; Arman Kulkarni; Nabil Alqam; Lucas F Lopes; Diego Vieira; David A Bennett; Julie A Schneider
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Linking cortical atrophy to white matter hyperintensities of presumed vascular origin.

Authors:  Carola Mayer; Benedikt M Frey; Eckhard Schlemm; Marvin Petersen; Kristin Engelke; Uta Hanning; Annika Jagodzinski; Katrin Borof; Jens Fiehler; Christian Gerloff; Götz Thomalla; Bastian Cheng
Journal:  J Cereb Blood Flow Metab       Date:  2020-12-01       Impact factor: 6.200

4.  Connectomic-genetic signatures in the cerebral small vessel disease.

Authors:  Raquel Gutiérrez-Zúñiga; Ibai Diez; Elisenda Bueichekú; Chan-Mi Kim; William Orwig; Victor Montal; Blanca Fuentes; Exuperio Díez-Tejedor; Maria Gutiérrez Fernández; Jorge Sepulcre
Journal:  Neurobiol Dis       Date:  2022-02-26       Impact factor: 5.996

5.  Association Between Antemortem FLAIR White Matter Hyperintensities and Neuropathology in Brain Donors Exposed to Repetitive Head Impacts.

Authors:  Madeline Uretsky; Sylvain Bouix; Ronald J Killiany; Yorghos Tripodis; Brett Martin; Joseph Palmisano; Asim Z Mian; Karen Buch; Chad Farris; Daniel H Daneshvar; Brigid Dwyer; Lee Goldstein; Douglas Katz; Christopher Nowinski; Robert Cantu; Neil Kowall; Bertrand Russell Huber; Robert A Stern; Victor E Alvarez; Thor D Stein; Ann McKee; Jesse Mez; Michael L Alosco
Journal:  Neurology       Date:  2021-11-24       Impact factor: 9.910

Review 6.  Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods.

Authors:  Mohamad Habes; Michel J Grothe; Birkan Tunc; Corey McMillan; David A Wolk; Christos Davatzikos
Journal:  Biol Psychiatry       Date:  2020-01-31       Impact factor: 13.382

7.  Association of White Matter Hyperintensities With HIV Status and Vascular Risk Factors.

Authors:  Yair Mina; Tianxia Wu; Hsing-Chuan Hsieh; Dima A Hammoud; Swati Shah; Chuen-Yen Lau; Lillian Ham; Joseph Snow; Elizabeth Horne; Anuradha Ganesan; Stanley I Rapoport; Edmund C Tramont; Daniel S Reich; Brian K Agan; Avindra Nath; Bryan R Smith
Journal:  Neurology       Date:  2021-02-26       Impact factor: 9.910

8.  Show Me Your White Matter, I Will Tell You Who You Are ….

Authors:  Gregory Kuchcinski; Clinton B Wright
Journal:  Stroke       Date:  2021-01-07       Impact factor: 7.914

9.  Older age and male sex are associated with higher cerebrovascular impedance.

Authors:  Jun Sugawara; Takashi Tarumi; Changyang Xing; Jie Liu; Tsubasa Tomoto; Evan P Pasha; Rong Zhang
Journal:  J Appl Physiol (1985)       Date:  2020-11-05

10.  Cognitive Function and White Matter Lesions in Medication-Overuse Headache.

Authors:  Yue Xiang; Shenggen Chen; Hanbin Lin; Wenting Xiong; Zhenyang Zheng
Journal:  J Pain Res       Date:  2021-06-17       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.